Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
This study has been completed.
Study NCT00041717   Information provided by Acorda Therapeutics
First Received: July 12, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spinal Cord Injury
Muscle Spasticity
Additional conditions recognized in this trial
Spinal Cord Injuries
More general conditions related to this trial
Central Nervous System Diseases
Disorders of Environmental Origin
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Signs and Symptoms
Spinal Cord Diseases
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
Fampridine-SR
Additional drug interventions recognized in this trial
4-Aminopyridine
More general drug interventions related to this trial
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Potassium Channel Blockers
Therapeutic Uses
Sponsors listed in this trial
Acorda Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services